There are 3397 resources available
Non-metastatic NSCLC and other thoracic malignancies
Presenter: Jarushka Naidoo
Session: Scientific Congress Highlights 2
Resources:
Slides
Webcast
Investigational immunotherapy
Presenter: Jessica Hassel
Session: Scientific Congress Highlights 1
Resources:
Slides
Webcast
NSCLC, metastatic
Presenter: Giulia Pasello
Session: Scientific Congress Highlights 2
Resources:
Slides
Webcast
The Need for New Approaches in Locally Advanced dMMR/MSI-H CRC
Presenter: Jenny Seligmann
Session: GSK - The Need for Better Patient Outcomes: Latest Investigational Approaches for dMMR/MSI-H CRC
Resources:
Webcast
Locally Advanced dMMR/MSI-H Rectal Cancer: New Approaches Under Investigation
Presenter: Aparna Parikh
Session: GSK - The Need for Better Patient Outcomes: Latest Investigational Approaches for dMMR/MSI-H CRC
Resources:
Webcast
Locally Advanced dMMR/MSI-H Colon Cancer: New Approaches Under Investigation
Presenter: Volker Heinemann
Session: GSK - The Need for Better Patient Outcomes: Latest Investigational Approaches for dMMR/MSI-H CRC
Resources:
Webcast
The Multidisciplinary Approach to Locally Advanced dMMR/MSI-H CRC: Reducing the Patient Burden
Presenter: Jenny Seligmann
Session: GSK - The Need for Better Patient Outcomes: Latest Investigational Approaches for dMMR/MSI-H CRC
Resources:
Webcast
Q&A | Panel Discussion
Presenter: All Speakers
Session: GSK - The Need for Better Patient Outcomes: Latest Investigational Approaches for dMMR/MSI-H CRC
Resources:
Webcast
LBA11 - Datopotamab deruxtecan (Dato-DXd) vs chemotherapy in previously-treated inoperable or metastatic hormone receptor-positive, HER2-negative (HR+/HER2–) breast cancer (BC): Primary results from the randomised phase III TROPION-Breast01 trial
Presenter: Aditya Bardia
Session: Presidential 3
Resources:
Abstract
Slides
Webcast
1692MO - Is project Orbis successful? The Swiss perspective
Presenter: Matea Pavic
Session: Mini oral session - Policy and preventive strategies
Resources:
Abstract
Slides
Webcast